Patents by Inventor Ryan Loughlin

Ryan Loughlin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Contraceptive regimen including reduced level of estrogen
    Patent number: 12138270
    Abstract: A contraceptive regimen that provides for a reduced level of estrogen. The contraceptive regimen can be used for the treatment of symptoms associated with endometriosis or fibroids.
    Type: Grant
    Filed: September 23, 2021
    Date of Patent: November 12, 2024
    Assignee: Millicent Pharma Limited
    Inventors: Roger M. Boissonneault, Ryan Loughlin
  • ORODISPERSIBLE FORMULATIONS
    Publication number: 20230346695
    Abstract: An orodispersible formulation for contraception or hormone replacement therapy containing an estrogen and a progestogen that has sufficient hardness, disintegration time and friability.
    Type: Application
    Filed: June 24, 2021
    Publication date: November 2, 2023
    Inventors: Ryan Loughlin, Roger M. Boissonneault
  • OPIOID ANTAGONIST FORMULATIONS
    Publication number: 20230149388
    Abstract: The present disclosure relates to pharmaceutical compositions comprising an opioid antagonist, isotonicity agent, a preservative agent, a stabilizing agent and citric acid. The pharmaceutical compositions are stable under various storage conditions.
    Type: Application
    Filed: April 19, 2021
    Publication date: May 18, 2023
    Inventors: Amir FUKHARI, Ryan LOUGHLIN, Vladimir SAVRANSKY, Andrew WALKER
  • ORODISPERSIBLE FORMULATIONS
    Publication number: 20230080934
    Abstract: An orodispersible formulation for contraception or hormone replacement therapy containing an estrogen and a progestogen that has sufficient hardness, disintegration time and friability.
    Type: Application
    Filed: October 14, 2022
    Publication date: March 16, 2023
    Inventors: Ryan Loughlin, Roger M. Boissonneault
  • CONTRACEPTIVE REGIMEN INCLUDING REDUCED LEVEL OF ESTROGEN
    Publication number: 20230070977
    Abstract: A contraceptive regimen that provides for a reduced level of estrogen. The contraceptive regimen can be used for the treatment of symptoms associated with endometriosis or fibroids.
    Type: Application
    Filed: September 23, 2021
    Publication date: March 9, 2023
    Inventors: Roger M. Boissonneault, Ryan Loughlin
  • ORODISPERSIBLE FORMULATIONS
    Publication number: 20220331337
    Abstract: An orodispersible formulation for contraception or hormone replacement therapy containing an estrogen and a progestogen that has sufficient hardness, disintegration time and friability.
    Type: Application
    Filed: July 6, 2022
    Publication date: October 20, 2022
    Inventors: Ryan Loughlin, Roger M. Boissonneault
  • LOW-TEMPERATURE STABLE OPIOID ANTAGONIST SOLUTIONS
    Publication number: 20200352934
    Abstract: The present invention relates to pharmaceutical compositions comprising an opioid antagonist, PG, and an isotonicity agent. The pharmaceutical compositions are stable at temperatures as low as ?5° C. or lower. Methods of using the pharmaceutical compositions are also disclosed.
    Type: Application
    Filed: September 28, 2018
    Publication date: November 12, 2020
    Inventors: Ryan LOUGHLIN, Fintan KEEGAN, Gerard Robert BELL
  • 5-aminosalicylic acid capsule formulation
    Patent number: 10688057
    Abstract: A dosage form comprising a capsule containing one or more tablets of 5-aminosalicylic acid or a salt thereof as an active ingredient where each of the one or more tablets is enterically coated is disclosed.
    Type: Grant
    Filed: March 11, 2019
    Date of Patent: June 23, 2020
    Assignee: Allergan Pharmaceuticals International Limited
    Inventors: Emma Boyd, Deborah Leigh Caldwell, Catherine Coulter, Ryan Loughlin, Stephen McCullagh
  • 5-AMINOSALICYLIC ACID CAPSULE FORMULATION
    Publication number: 20190201348
    Abstract: A dosage form comprising a capsule containing one or more tablets of 5-aminosalicylic acid or a salt thereof as an active ingredient where each of the one or more tablets is enterically coated is disclosed.
    Type: Application
    Filed: March 11, 2019
    Publication date: July 4, 2019
    Inventors: Emma Boyd, Deborah Leigh Caldwell, Catherine Coulter, Ryan Loughlin, Stephen McCullagh
  • 5-aminosalicyclic acid capsule formulation
    Patent number: 10265273
    Abstract: A dosage form comprising a capsule containing one or more tablets of 5-aminosalicylic acid or a salt thereof as an active ingredient where each of the one or more tablets is enterically coated is disclosed.
    Type: Grant
    Filed: September 2, 2014
    Date of Patent: April 23, 2019
    Assignee: ALLERGAN PHARMACEUTICAL INTERNATIONAL LIMITED
    Inventors: Emma Boyd, Deborah Leigh Caldwell, Catherine Coulter, Ryan Loughlin, Stephen McCullagh
  • LOW-TEMPERATURE STABLE OPIOID ANTAGONIST SOLUTIONS
    Publication number: 20180193332
    Abstract: The present invention relates to pharmaceutical compositions comprising an opioid antagonist, PG, and an isotonicity agent. The pharmaceutical compositions are stable at temperatures as low as ?5° C. or lower. Methods of using the pharmaceutical compositions are also disclosed.
    Type: Application
    Filed: January 8, 2018
    Publication date: July 12, 2018
    Inventors: Ryan Loughlin, Fintan Keegan, Robert Gerard Bell
  • 5-AMINOSALICYLIC ACID CAPSULE FORMULATION
    Publication number: 20140370083
    Abstract: A dosage form comprising a capsule containing one or more tablets of 5-aminosalicylic acid or a salt thereof as an active ingredient where each of the one or more tablets is enterically coated is disclosed.
    Type: Application
    Filed: September 2, 2014
    Publication date: December 18, 2014
    Inventors: Emma Boyd, Deborah Leigh Caldwell, Catherine Coulter, Ryan Loughlin, Stephen McCullagh
  • 5-AMINOSALICYLIC ACID CAPSULE FORMULATION
    Publication number: 20140141075
    Abstract: A dosage form comprising a capsule containing one or more tablets of 5-aminosalicylic acid or a salt thereof as an active ingredient where each of the one or more tablets is enterically coated is disclosed.
    Type: Application
    Filed: November 21, 2012
    Publication date: May 22, 2014
    Inventors: Emma Boyd, Deborah Leigh Caldwell, Catherine Coulter, Ryan Loughlin, Stephen McCullagh